29 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C … that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted
ARS
ixlztqtzld vr3
28 Apr 23
Annual report to shareholders
12:00am
CORRESP
8kn9r1 3yi0el
19 Jul 21
Correspondence with SEC
12:00am
S-1/A
EX-2.1
sq24vu5t
8 Jul 21
IPO registration (amended)
5:04pm
10-K
7ufsmm
22 Mar 22
Annual report
5:20pm
S-1
EX-10.11
e25 kp6w4mmbw1zp5
30 Jun 21
IPO registration
3:20pm
DRS/A
EX-10.11
aic0phbauaj6 va
16 Jun 21
Draft registration statement (amended)
12:00am
S-1
EX-10.12
l9h98
30 Jun 21
IPO registration
3:20pm
DRS/A
hqcll ii76b4c
16 Jun 21
Draft registration statement (amended)
12:00am
S-1
7b7vt82hn
30 Jun 21
IPO registration
3:20pm
424B4
foi6eqzj6u7
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
t2szd9ria
8 Jul 21
IPO registration (amended)
5:04pm